{'fraction_non_alphanumeric': 0.019230769230769232, 'fraction_numerical': 0.012237762237762238, 'mean_word_length': 5.2967032967032965, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Is It Time for Safeguards in the Adoption of Robotic Surgery?

On February 28, 2019 the United States Food and Drug Administration (FDA) released a safety communication that cautioned patients, surgeons, and health care organizations about the use of robotic-assisted surgical systems for the treatment of breast and other cancers.1 This communication cited concerns that evidence to support the use of robotic-assisted surgery for the treatment of these cancers was limited and may even be associated with shorter long-term survival compared to other surgical approaches.